Voyager Therapeutics Inc (VYGR) support and resistance · rev $5.8M
Voyager Therapeutics Inc (VYGR) is a biotechnology company listed on NASDAQ.
This page maps Voyager Therapeutics Inc (VYGR) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported VYGR revenue for 2026-06-30 was $5.8M. Net income was -$52.4M. VYGR currently screens at market cap $225.4M.
VYGR currently screens at market cap $225.4M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new VYGR 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the VYGR quote page for the session range and the stock page for the full model.
Not investment advice.